Bernstein Liebhard LLP Investigates Cases Linking Cellphone Radiation to Cancer

Fosamax Femur Fracture Lawsuit Filed by Bernstein Liebhard LLP

DePuy Pinnacle Hip Implant Lawsuits Consolidated in the Northern District of Texas

Federal Fosamax Femur Fracture Lawsuits Consolidated in New Jersey District Court

U.S. Judicial Panel on Multidistrict Litigation Hears Oral Arguments on Fosamax Femur Fracture Litigation

Future of DePuy Pinnacle Hip Implant Lawsuits to be Determined by U.S. Judicial Panel on Multidistrict Litigation

Bernstein Liebhard LLP Applauds FDA’s Request that Hip Manufacturers Produce Data on Metal Poisoning and Hip Implants

Individual Denture Cream Lawsuit Settlements with GlaxoSmithKline Average $1 Million Each

Bernstein Liebhard LLP Investigates Topamax Cleft Lip and Cleft Palate Cases

New Femur Fracture Study Reinforces Earlier Findings Linking Osteoporosis Medications to Atypical Femur Fractures

Jeffrey S. Grand Joins Bernstein Liebhard LLP

Bernstein Liebhard LLP Applauds the Creation of Two National Joint Registries

Supreme Court of New Jersey Centralizes DePuy ASR Hip Implant Lawsuits

Senate Panel Reviews FDA’s Regulatory Process in Light of DePuy ASR Hip Recall

Lawsuits Concerning DePuy Pinnacle Hip Implants Moving Forward

Bernstein Liebhard LLP Reports on Latest Developments in Femur Fracture Lawsuits Against Merck

Bernstein Liebhard LLP Reports that Preliminary Discovery is Underway in DePuy MDL

Bernstein Liebhard Reports on New Study Suggesting DePuy Hip Failure Rate as High as 49 Percent

Bernstein Liebhard LLP Supports FDA Recommendation that Denture Cream Manufacturers Stop Using Zinc

Court To Hold First Status Conference In DePuy Hip Recall Litigation Cases